AK
Arvind Kumar Singh
About Arvind Kumar Singh
Data last updated:
Arvind Kumar Singh is a Director at Morningg Life Pharmaceuticals Private Limited (since 2019) and Director at Morningg Life Sciences Private Limited (since 2026). The companies operate in Trading. The largest current company by reported revenue is Morningg Life Pharmaceuticals Private Limited at ₹1.89 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 May 2019 | 2019 | ₹1.89 Cr (FY 2025) | Active | |
| Director | 28 Jul 2026 | 2026 | Active |
Board colleagues of Arvind Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shivendra Pratap Singh | 08441624 | Morningg Life Pharmaceuticals Private Limited | Director |
| Sadhana Singh | 11853928 | Morningg Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arvind Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arvind Kumar Singh
Arvind Kumar Singh currently holds 2 directorships: Morningg Life Pharmaceuticals Private Limited (Director, since 02 May 2019, revenue ₹1.89 Cr (FY 2025)); Morningg Life Sciences Private Limited (Director, since 28 Jul 2026).
Arvind Kumar Singh was first appointed on 02 May 2019 as Director at Morningg Life Pharmaceuticals Private Limited. The most recent appointment on record is 28 Jul 2026 at Morningg Life Sciences Private Limited.
The current boards of Arvind Kumar Singh's companies include Shivendra Pratap Singh (Morningg Life Pharmaceuticals Private Limited), Sadhana Singh (Morningg Life Sciences Private Limited).